| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/05/2007 | WO2007015848A9 Improved methods and compositions for increasing longevity and protein yield from a cell culture |
| 04/05/2007 | WO2006133286A3 Treatment of tnf antagonist-resistant inflammatory disorders and related methods |
| 04/05/2007 | WO2006119983A3 Genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy |
| 04/05/2007 | WO2006117327A3 CELLULAR ASSAY METHOD FOR IDENTIFYING PKC-θ INHIBITORS |
| 04/05/2007 | WO2006074418A3 Ovr110 antibody compositions and methods of use |
| 04/05/2007 | WO2006071877A3 Orally deliverable and anti-toxin antibodies and methods for making and using them |
| 04/05/2007 | WO2006053301A3 Fc variants with altered binding to fcrn |
| 04/05/2007 | WO2006026977A3 Polypeptides and method for specifically binding prions |
| 04/05/2007 | WO2005103697A3 Immunoassays for buprenorphine and norbuprenorphine |
| 04/05/2007 | WO2005094159A3 Methods of identifying neoplasm-specific antibodies and uses thereof |
| 04/05/2007 | WO2005014780A3 Prostate stem cell antigen (psca) variants and subsequences thereof |
| 04/05/2007 | WO2004093808A3 Novel tumor-associated antigens |
| 04/05/2007 | US20070078260 Chemokine panec-2 polynucleotides, polypeptides, antibodies and methods of making and using them |
| 04/05/2007 | US20070077628 Polynucleotides, polypeptides and antibodies and use thereof in treating tsg101-associated diseases |
| 04/05/2007 | US20070077627 Zcytor17 ligand cytokine; immunostimulators system, and proliferation and/or development of hematopoietic cells in vitro and in vivo; transcription, gene expression, culturing; anticarcinogenic and antiinflammatory agents; diabetes, pancreatitis, inflammatory bowel disease; autoimmune diseases |
| 04/05/2007 | US20070077625 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide |
| 04/05/2007 | US20070077624 Recombinant production of mixtures of antibodies |
| 04/05/2007 | US20070077623 Capable of inducing chondrocyte proliferation; Chinese Hamster Ovary, an Escheria coli or a yeast host cell with an expression vector |
| 04/05/2007 | US20070077608 Conjugates of busulfan and immunogens and antigens thereof and quantification after crosslinking |
| 04/05/2007 | US20070077592 Hemipteran glutamate decarboxylase |
| 04/05/2007 | US20070077591 Novel polypeptide |
| 04/05/2007 | US20070077581 Oncoprotein protein kinase |
| 04/05/2007 | US20070077574 Fusion proteins; SARP genes/proteins; for treatment of cancer, diseases related to the regulation of SARP expression in tissue and bodily fluid samples, including cancers; monoclonal/polyclonal antibodies |
| 04/05/2007 | US20070077569 Transgenic cell which produces sucrose isomerases for use in generation of isomaltulose from sucrose; sugar substitute |
| 04/05/2007 | US20070077252 Laminin chains: diagnostic uses |
| 04/05/2007 | US20070077251 Lipoprotein associated phospholipase A2, inhibitors thereof and use of the same in diagnosis and therapy |
| 04/05/2007 | US20070077249 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor |
| 04/05/2007 | US20070077248 Tumour necrosis factor binding ligands |
| 04/05/2007 | US20070077247 Receptor on the surface of activated T-cells: ACT-4 |
| 04/05/2007 | US20070077246 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity |
| 04/05/2007 | US20070077244 Inhibitor protein of the wnt signal pathway |
| 04/05/2007 | US20070077243 Method for making humanized antibodies |
| 04/05/2007 | US20070077242 Tumor necrosis factor specific immunoglobulin for use in treatment and prevention of tumor disorder; tissue targeted therapy |
| 04/05/2007 | US20070077241 Activation of Lymphocyte Populations Expressing NKG2D Using Anti-NKG2D Antibodies and Ligand Derivatives |
| 04/05/2007 | US20070077240 having determined antigen specificity, and having a variable fragment which is obtainable from a camelid heavy-chain immunoglobulin having two heavy polypeptide chains capable of recognizing and binding an antigen and which is further devoid of polypeptide light chains |
| 04/05/2007 | US20070077199 Humanized collagen antibodies and related methods |
| 04/05/2007 | CA2624135A1 T-cell adhesion molecule and antibody thereto |
| 04/05/2007 | CA2623841A1 Methods of identifying agents capable of tmem30a mediated transmigration across the blood brain barrier (bbb) |
| 04/05/2007 | CA2623659A1 Targeted delivery of compounds using multimerization technology |
| 04/05/2007 | CA2623652A1 Antibody-drug conjugates and methods of use |
| 04/05/2007 | CA2623554A1 Methods and therapies for treating inflammatory conditions with exposed collagen |
| 04/05/2007 | CA2623517A1 Antibodies with simultaneous subsite specificities to protein and lipid epitopes |
| 04/05/2007 | CA2623429A1 Interleukin-13 antibody composition |
| 04/05/2007 | CA2623236A1 Human monoclonal antibodies to cd70 |
| 04/05/2007 | CA2621623A1 Il-17a and il-17f antagonists and methods of using the same |
| 04/04/2007 | EP1770167A2 Regeneration |
| 04/04/2007 | EP1770164A2 Streptococcus pneumoniae antigens and vaccines |
| 04/04/2007 | EP1770163A2 Antagonists of interleukin-15 |
| 04/04/2007 | EP1770162A1 Immunological compositions to modulate myostatin in vertebrate subjects |
| 04/04/2007 | EP1770160A1 Monocyte-derived nucleic acids and related compositions and methods |
| 04/04/2007 | EP1770101A1 Antibodies against caspase-8, their preparation and use |
| 04/04/2007 | EP1769807A1 Graft rejection suppressors |
| 04/04/2007 | EP1769250A1 Immunoassay for determining the release of neurotensin into the circulation |
| 04/04/2007 | EP1769245A2 Identification and engineering of antibodies with variant fc regions and methods of using the same |
| 04/04/2007 | EP1769243A2 Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule |
| 04/04/2007 | EP1769003A1 HIGH AFFINITY ANTI-TNF-alpha ANTIBODIES AND METHOD |
| 04/04/2007 | EP1769002A1 Monolocal antibodies that target pathological assemblies of amyloid beta; (abeta) |
| 04/04/2007 | EP1769001A2 Methods of detecting a phenotype of a polymorphic protein |
| 04/04/2007 | EP1769000A1 Expression-enhanced polypeptides |
| 04/04/2007 | EP1768698A2 Immunogenic compositions comprising hmgb1 polypeptides |
| 04/04/2007 | EP1573323A4 Prion protein ligands and methods of use |
| 04/04/2007 | EP1414858B1 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 04/04/2007 | EP1352056B1 Polypeptides capable of eliciting an immune reaction against cancer |
| 04/04/2007 | EP1226256B1 Recombinant bifunctional fusion proteins for the clearance of variable viruses |
| 04/04/2007 | EP1184392B1 Stabilized denatured lipoprotein and process for producing the same |
| 04/04/2007 | EP1137786B1 Virus coat protein/receptor chimeras and methods of use |
| 04/04/2007 | EP0991756B1 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 04/04/2007 | EP0951292B1 Treating an ischemic disorder and improving stroke outcome |
| 04/04/2007 | EP0946591B1 Cloned glucagon-like peptide-2 receptors |
| 04/04/2007 | CN1942767A Gastric inhibitory polypeptide diagnostic test for detecting susceptibility to type-2 diabetes, impaired glucose tolerance, or impaired fasting glucose |
| 04/04/2007 | CN1942588A Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 04/04/2007 | CN1942585A Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-lenght virus genome replicative cell having the nucleic acid construct transferred thereinto and metho |
| 04/04/2007 | CN1942581A Antibody with osteoclast-related protein as target |
| 04/04/2007 | CN1942483A Anti-P-selectin antibodies |
| 04/04/2007 | CN1942482A Protein ligands for NKG2D and UL16 receptors and uses thereof |
| 04/04/2007 | CN1942203A Screening method using antibody heavy chains |
| 04/04/2007 | CN1942199A Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 04/04/2007 | CN1940069A Ig light chain variable region sequence and CDR3 sequence from human cancers and their use |
| 04/04/2007 | CN1940068A Novel receptor nucleic acids and polypeptides |
| 04/04/2007 | CN1940062A Liver-cancer stem cell, its separation and use |
| 04/04/2007 | CN1939931A Igy antibody and method for separating it from eggs of anseriformes selectively |
| 04/04/2007 | CN1939930A Low-molecular TPO agonist antibodies |
| 04/04/2007 | CN1308451C Tumor necrosis factor related ligand |
| 04/04/2007 | CN1308448C Degraded TPO agonist antibody |
| 04/04/2007 | CN1308447C Degraded agonist antibody |
| 04/04/2007 | CN1308347C Compositions and methods for cancer treatment by selectively inhibiting VEGF |
| 04/04/2007 | CN1308346C Novel human phosphotidylethanolamine binding protein, its coding sequence and application |
| 04/03/2007 | USRE39548 Interleukin-5 specific recombinant antibodies |
| 04/03/2007 | US7199279 Expression vector comprising hydrolase regulatory sequences, matrix attachment region (MAR) and transcriptional enhancer for use as gene transfer tools |
| 04/03/2007 | US7199234 Nucleotide sequences coding telomerase reverse transcriptase (TRT) for diagnosing and treating cancers; antiproliferative agents |
| 04/03/2007 | US7199232 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof |
| 04/03/2007 | US7199231 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology |
| 04/03/2007 | US7199229 Comprises serine protease for diagnosis, prognosis and treatment of cell proliferative disorders |
| 04/03/2007 | US7199225 Stimulating differentiation in growth of osteoblasts and osteoclasts; wound healing of bone fractures and de novo bone formation; osteoporosis; bone cancer treatment; polynucleotide encoding polypeptide; genetic engineering |
| 04/03/2007 | US7199224 Antibodies that bind TNF-α converting enzyme |
| 04/03/2007 | US7199220 Comprises nucleotide sequences coding human leukocyte antigen conjugate for use in diagnosis, prognosis and treatment of cell proliferative disorders; antiproliferative agents |
| 04/03/2007 | US7199218 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer |
| 04/03/2007 | US7198954 Methods for predicting pregnancy outcome in a subject by hCG assay |
| 04/03/2007 | US7198944 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 04/03/2007 | US7198928 Human COX-1 alternatively spliced variants and methods of using same |